Physiologic role of somatostatin. Insulin release from rat islets treated by somatostatin antiserum. 1977

H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba

In order to clarify the physiologic role of somatostatin in insulin release, rat pancreatic islets treated by somatostatin antiserum were incubated in media containing various concentrations of glucose. Insulin release from antiserum-treated islets was significantly elevated above that from nontreated ones at 3.3 and 8.3 mM glucose, while the former was not different from the latter at 16.7 mM glucose. It is suggested that somatostatin plays an important role in the regulation of insulin release in the physiologic range of glucose concentration.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
October 1977, Nihon Naibunpi Gakkai zasshi,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
October 1976, FEBS letters,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
June 1975, FEBS letters,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
October 1980, Research communications in chemical pathology and pharmacology,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
June 1979, Diabetes,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
September 1977, FEBS letters,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
January 1982, Peptides,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
July 1985, Diabetes research (Edinburgh, Scotland),
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
December 1980, The Journal of clinical investigation,
H Taniguchi, and M Utsumi, and M Hasegawa, and T Kobayashi, and Y Watanabe, and K Murakami, and M Seki, and A Tsutou, and H Makimura, and M Sakoda, and S Baba
November 1973, Diabetes,
Copied contents to your clipboard!